SCHEMBL10352891

SCHEMBL10352891

COc1ccc2c(C(=S)N(C)CC(=O)N(C)C)cccc2c1C(F)(F)F

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 1/20 0.82
AKR1A1 P14550 1/20 0.82
AKR1B1 P15121 1/20 0.82
CYP2C9 P11712 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
STAT6 P42226 1/20 0.36
HSD17B10 Q99714 1/20 0.36
POLB P06746 1/20 0.35
MAPT P10636 3/20 0.34
CDC25B P30305 2/20 0.33
HPGDS O60760 1/20 0.33
GAA P10253 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
PLK1 P53350 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tolrestat SCHEMBL20769758 0.90 AKR1B10 (1.00) AKR1B10AKR1A1AKR1B1CYP2C9ALDH1A1
Tolrestat SCHEMBL29375449 0.90 AKR1B10 (1.00) AKR1B10AKR1A1AKR1B1CYP2C9ALDH1A1
Tolrestat SCHEMBL49326 0.90 AKR1B10 (1.00) AKR1B10AKR1A1AKR1B1CYP2C9ALDH1A1
Tolrestat SCHEMBL10391296 0.89 AKR1B10 (0.82) AKR1B10AKR1A1AKR1B1CYP2C9ALDH1A1
Tolrestat SCHEMBL10391297 0.89 AKR1B10 (0.98) AKR1B10AKR1A1AKR1B1CYP2C9ALDH1A1
SCHEMBL9761952 0.89 AKR1B10 (0.82) AKR1B10AKR1A1AKR1B1CYP2C9ALDH1A1
SCHEMBL10352852 0.87 AKR1B10 (0.79) AKR1B10AKR1A1AKR1B1CYP2C9ALDH1A1
SCHEMBL10352848 0.85 AKR1B10 (0.74) AKR1B10AKR1A1AKR1B1CYP2C9ALDH1A1
SCHEMBL10352853 0.85 AKR1B10 (0.74) AKR1B10AKR1A1AKR1B1CYP2C9ALDH1A1
SCHEMBL10352917 0.83 AKR1B10 (0.69) AKR1B10AKR1A1AKR1B1CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0206546-B1 N-[(1-naphthalenyl)-thioxomethyl and carbonyl]-N-methylglycinamide derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1990-08-08 EP claimed
US-4672058-A N[[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]-thioxomethyl]-N-methylglycinamides AMERICAN HOME PRODUCTS CORPORATION (US) 1987-06-09 US claimed
EP-0206546-A2 N-[(1-naphthalenyl)-thioxomethyl and carbonyl]-N-methylglycinamide derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1986-12-30 EP claimed
EP-0206546-B1 N-[(1-naphthalenyl)-thioxomethyl and carbonyl]-N-methylglycinamide derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1990-08-08 EP disclosed
US-4672058-A N[[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]-thioxomethyl]-N-methylglycinamides AMERICAN HOME PRODUCTS CORPORATION (US) 1987-06-09 US disclosed
US-4672059-A ENZYME INHIBITORS; PREVENT OR TREAT DIABETIC COMPLICATIONS AMERICAN HOME PRODUCTS CORPORATION (US) 1987-06-09 US disclosed
EP-0206546-A2 N-[(1-naphthalenyl)-thioxomethyl and carbonyl]-N-methylglycinamide derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1986-12-30 EP disclosed